医疗保健专业人员必须与患者和家属沟通。他们必须在临终药物治疗中做出明智、现实和适当的决定

Evidence Based Journals Pub Date : 2019-11-12 DOI:10.1136/ebnurs-2019-103179

Amanda J Lee

{"title":"医疗保健专业人员必须与患者和家属沟通。他们必须在临终药物治疗中做出明智、现实和适当的决定","authors":"Amanda J Lee","doi":"10.1136/ebnurs-2019-103179","DOIUrl":null,"url":null,"abstract":"Commentary on: Morin L, Wastesson JW, Laroche ML, et al . How many older adults receive drugs of questionable clinical benefit near the end of life? A cohort study. Palliat Med 2019;33:1080–90. doi: 10.1177/0269216319854013.\n\n\n\nUse of a variety of drugs (polypharmacy) is required to manage complex disease processes. At the end of life, the focus of ‘treatment’ changes from extending survival to symptom management—therefore, aims of treatments change, requiring different pharmaceutical …","PeriodicalId":12178,"journal":{"name":"Evidence Based Journals","volume":"139 1","pages":"12 - 12"},"PeriodicalIF":0.0000,"publicationDate":"2019-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Healthcare professionals must communicate with patients and relatives. They must enable informed, realistic and appropriate decisions in end-of-life pharmacotherapy\",\"authors\":\"Amanda J Lee\",\"doi\":\"10.1136/ebnurs-2019-103179\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Commentary on: Morin L, Wastesson JW, Laroche ML, et al . How many older adults receive drugs of questionable clinical benefit near the end of life? A cohort study. Palliat Med 2019;33:1080–90. doi: 10.1177/0269216319854013.\\n\\n\\n\\nUse of a variety of drugs (polypharmacy) is required to manage complex disease processes. At the end of life, the focus of ‘treatment’ changes from extending survival to symptom management—therefore, aims of treatments change, requiring different pharmaceutical …\",\"PeriodicalId\":12178,\"journal\":{\"name\":\"Evidence Based Journals\",\"volume\":\"139 1\",\"pages\":\"12 - 12\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-11-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Evidence Based Journals\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/ebnurs-2019-103179\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Evidence Based Journals","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ebnurs-2019-103179","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

评述:Morin L, Wastesson JW, Laroche ML，等。有多少老年人在临终前接受了临床疗效有问题的药物?一项队列研究。中华医学杂志2019;33:1080-90。doi: 10.1177 / 0269216319854013。需要使用多种药物(综合用药)来管理复杂的疾病过程。在生命的尽头，“治疗”的重点从延长生存时间转变为症状管理，因此，治疗的目的也发生了变化，需要不同的药物治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Healthcare professionals must communicate with patients and relatives. They must enable informed, realistic and appropriate decisions in end-of-life pharmacotherapy

Commentary on: Morin L, Wastesson JW, Laroche ML, et al . How many older adults receive drugs of questionable clinical benefit near the end of life? A cohort study. Palliat Med 2019;33:1080–90. doi: 10.1177/0269216319854013. Use of a variety of drugs (polypharmacy) is required to manage complex disease processes. At the end of life, the focus of ‘treatment’ changes from extending survival to symptom management—therefore, aims of treatments change, requiring different pharmaceutical …

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Evidence Based Journals

自引率

0.00%

发文量